- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07593001
TIME MANAGEMENT DURING HAEMODIALYSIS ON ANXIETY AND FEAR IN CHILDREN
THE EFFECT OF THE TRAINING GIVEN ON TIME MANAGEMENT DURING HAEMODIALYSIS ON ANXIETY AND FEAR IN CHILDREN
Aim: This study aims to determine the effect of time management training on anxiety and fear levels in children undergoing haemodialysis treatment. It is anticipated that the structured time management training provided to children will contribute to the treatment process.
Method: This study has a randomised controlled experimental design. The study was conducted at the Gaziantep University Sahinbey Research and Application Hospital Children's Nephrology Diseases Hemodialysis Unit between 1 November 2025 and 1 April 2026. The study sample consisted of children aged 9-12 undergoing hemodialysis treatment at this unit. The sample group was randomly divided into intervention and control groups. The intervention group received training after the pre-test, and the training's effectiveness was evaluated one week and one month later. The control group received routine care. Data were collected using a questionnaire, the State-Trait Anxiety Inventory for Children, and the Medical Procedure Fear Scale.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Gaziantep, Turquie (Türkiye), 27310
- Gaziantep University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
La description
Inclusion Criteria:
- Children aged 9-12,
- Children who can speak and understand Turkish,
- Children without communication problems,
- Children without learning disabilities,
- Children approved by their families,
- Children without physical disabilities.
Exclusion Criteria:
- Children who refuse to participate in the study,
- Children who do not speak Turkish,
- Children with communication problems,
- Children with learning disabilities,
- Children with intellectual disabilities.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Entraînement
|
The intervention group received training after the pre-test, and the training's effectiveness was evaluated one week and one month later.
There is no actual intervention, just rutin care
|
|
Aucune intervention: Control
Rutin care
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
the State Anxiety Inventory (Pre-training)
Délai: 2 months
|
After obtaining their consent during the first interview, the State Anxiety Inventory, was administered as pre-tests.
|
2 months
|
|
the Medical Procedure Fear Scale (Pre-training)
Délai: 2 mounts
|
After obtaining their consent during the first interview the Medical Procedure Fear Scale was administered as pre-tests.
|
2 mounts
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
the State Anxiety Inventory, (Post test)
Délai: 4 months
|
When evaluating the results of the first measurement one week after training (Final test 1)) State Anxiety Inventory was assessed.
|
4 months
|
|
the Medical Procedure Fear Scale (Post test)
Délai: 4 months
|
When evaluating the results of the first measurement one week after training (Final test 1)) the Medical Procedure Fear Scale was assessed.
|
4 months
|
|
the State Anxiety Inventory (Post test)
Délai: 5 mounts
|
When evaluating the results of the second measurement one month after training (Final test 2)) the the State Anxiety Inventory was assessed.
|
5 mounts
|
|
the Medical Procedure Fear Scale (Post test)
Délai: 5 mounts
|
When evaluating the results of the second measurement one month after training (Final test 2)) the Medical Procedure Fear Scale was assessed.
|
5 mounts
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Publications générales
- Raina M, Shah R, Hu J, Pember B, Cahill T, Bunchman T, Yap HK, McCulloch M. The global health burden of pediatric chronic kidney disease: An analysis of the Global Burden of Disease database from 1990 to 2021. PLoS One. 2025 May 27;20(5):e0323257. doi: 10.1371/journal.pone.0323257. eCollection 2025.
- Park, M. J. (2023). Anemia in children with chronic kidney disease: Current insights. Children's Kidney Journal, 7(3), 201-210.
- Panzarino V, Lesser J, Cassani FA. Pediatric Chronic Kidney Disease. Adv Pediatr. 2022 Aug;69(1):123-132. doi: 10.1016/j.yapd.2022.03.008.
- Hosseini T, Hooshmandja M, Noaparast M, Mojtahedzadeh R, Mohammadi A. Virtual reality exposure therapy to decrease anxiety before surgical invasive procedures in hemodialysis patients: an interventional study. BMC Nephrol. 2024 Jan 24;25(1):30. doi: 10.1186/s12882-024-03461-w.
- Francis, A., et al. (2024). Key pediatric considerations from the KDIGO 2024 CKD guidelines. JAMA Pediatrics, 178(5), 433-440.
- Cirillo L, De Chiara L, Innocenti S, Errichiello C, Romagnani P, Becherucci F. Chronic kidney disease in children: an update. Clin Kidney J. 2023 Apr 24;16(10):1600-1611. doi: 10.1093/ckj/sfad097. eCollection 2023 Oct.
- Akinkugbe, O., et al. (2024). Systematic review of CKD progression mechanisms in pediatric patients. Pediatric Nephrology, 39(4), 789-802.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- GaziantepU
- SBF.YLP.26.05 (Autre subvention/numéro de financement: Gaziantep University Scientific Research Project)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .